EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis

Maria Tomkins iD, Tara McDonnell, Leanne Cussen, Michael S Sagmeister, Imken Oestlund, Fozia Shaheen, Lorraine Harper iD, Rowan S Hardy iD, Angela E Taylor iD, Lorna C Gilligan, Wiebke Arlt iD, Marie McIlroy und 9 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae714 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Maria Tomkins und 20 weiteren Autor:innen. Beteiligte Einrichtung: Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland, Dub…. Hauptthemen laut MEDLINE: 11-beta-Hydroxysteroid Dehydrogenase Type 2, Androgens, Renal Insufficiency, Chronic, Testosterone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of South Africa, Irish Clinical Academic Training, HRB Emerging Clinician Scientist Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

11-Oxygenated androgens are a group of adrenal-derived steroids that require peripheral activation. In vitro data highlight a putative role for 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) in 11-oxygenated androgen biosynthesis, converting 11β-hydroxyandrostenedione to 11-ketoandrostenedione (11KA4), the direct precursor of the potent androgen 11-ketotestosterone (11KT). As the kidney is the major site of HSD11B2 expression, we hypothesized that patients with chronic kidney disease (CKD) would have reduced 11-oxygenated androgen biosynthesis due to impaired HSD11B2 activity.

Objective

To determine the role of HSD11B2 in 11-oxygenated androgen biosynthesis using a human CKD cohort alongside complementary cell culture and computational modeling approaches.

Methods

Cross-sectional observational study of patients with CKD (n = 85) and healthy controls (n = 46) measuring serum and urinary concentrations of glucocorticoids, and classic and 11-oxygenated androgens by liquid chromatography tandem mass spectrometry. A computational model of peripheral 11-oxygenated androgen biosynthesis was fitted to the serum data to calculate relative HSD11B2 expression levels for each participant.

Results

HSD11B2 activity declined with estimated glomerular filtration rate (eGFR), evidenced by higher cortisol/cortisone (E) ratios in patients with CKD than in controls (P < .0001). Serum concentrations of E, 11KA4, 11KT, and 11β-hydroxytestosterone were lower in patients with CKD than in controls (P < .0001 for each). A computational model based on enzyme kinetic parameters of HSD11B2, 11β-hydroxysteroid dehydrogenase type 1, 17β-hydroxysteroid dehydrogenase type 2, and aldo-keto reductase 1C3 confirmed HSD11B2 as the key enzyme responsible for reduced 11-oxygenated androgen biosynthesis in CKD. Predicted HSD11B2 expression correlated with eGFR.

Conclusion

This is the first in vivo study to confirm a central role for renal HSD11B2 in 11-oxygenated androgen biosynthesis. Determining the clinical implications of this observation for patients with CKD requires further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

11-beta-Hydroxysteroid Dehydrogenase Type 2AndrogensRenal Insufficiency, ChronicTestosteroneHumansMaleCross-Sectional StudiesMiddle AgedFemaleAgedAdultAndrostenedioneCase-Control Studies

Stichwörter der Autor:innen

11-oxygenated androgens11β-hydroxysteroid dehydrogenase type 2chronic kidney diseasesteroid biosynthesis

Substanzen

11-beta-Hydroxysteroid Dehydrogenase Type 2AndrogensTestosteroneHSD11B2 protein, human11-ketotestosterone11-hydroxyandrostenedioneAndrostenedione

Autor:innen und Institutionen

  • Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, D09 V2N0, Ireland.
  • Department of Endocrinology, Beaumont Hospital, Dublin, D09 V2N0, Ireland.
  • Steroid Metabolome Analysis Core (SMAC), Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Department of Nephrology, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
  • Department of Biochemistry, Stellenbosch University, Stellenbosch, 7600, South Africa.
  • Institute of Clinical Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

ORCID-Profile: Maria Tomkins, Lorraine Harper, Rowan S Hardy, Angela E Taylor, Wiebke Arlt, Karl-Heinz Storbeck, Michael W O'Reilly

Förderung

  • National Research Foundation of South Africa
  • Irish Clinical Academic Training
  • HRB Emerging Clinician Scientist Award
  • Medical Research Council Clinical Research Training Fellowship
  • DSI/NRF in South Africa via the SARChI initiative
  • Wellcome Trust
  • Health Research Board

Zitieren

APA

Tomkins, M., McDonnell, T., Cussen, L., Sagmeister, M. S., Oestlund, I., Shaheen, F., Harper, L., Hardy, R. S., Taylor, A. E., Gilligan, L. C., Arlt, W., McIlroy, M., de Freitas, D., Conlon, P., Magee, C., Denton, M., O'Seaghdha, C., Snoep, J. L., Storbeck, K. H., …, & O'Reilly, M. W. (2025). Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae714

Vancouver

Tomkins M, McDonnell T, Cussen L, Sagmeister MS, Oestlund I, Shaheen F, et al. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae714

BibTeX
@article{Tomkins2025,
  author = {Tomkins, Maria and McDonnell, Tara and Cussen, Leanne and Sagmeister, Michael S and Oestlund, Imken and Shaheen, Fozia and Harper, Lorraine and Hardy, Rowan S and Taylor, Angela E and Gilligan, Lorna C and Arlt, Wiebke and McIlroy, Marie and de Freitas, Declan and Conlon, Peter and Magee, Colm and Denton, Mark and O'Seaghdha, Conall and Snoep, Jacky L and Storbeck, Karl-Heinz and Sherlock, Mark and O'Reilly, Michael W},
  title = {Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen Biosynthesis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae714}
}
Kostenlos starten →